CLINICAL_TRIALS
trial_result
· 2014-03-19
Clinical Trial Update: Kremezin Study Against Renal Disease Progression in Korea [Phase 4]
Summary
A Phase 4 study evaluating Kremezin (AST-120) for chronic kidney disease in Korea has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Seoul National University Hospital | Conditions: Chronic Kidney Disease | Phase 4 | Status: COMPLETED